Butterfly Network, Inc. Class A (BFLY)

In November 2025, Butterfly Network entered a co-development and licensing agreement with Midjourney, contributing $6.8 million in revenue in Q4 2025. In February 2026, the company reported record quarterly revenue of $31.5 million and positive net cash flow of $6.3 million. In April 2026, Arun Nagdev, MD, was appointed as Chief Medical Officer – POCUS. In May 2026, Butterfly Network reported revenue of $26.53 million and a narrowed net loss, but the stock initially fell due to an EPS miss. The company reaffirmed its full-year 2026 revenue guidance of $117M–$121M and provided Q2 revenue guidance of $27M–$31M. Insider trading activity was also noted.

While specific detailed seasonality data is limited, analysis of seasonal charts suggests that November has the highest probability of a positive return for Butterfly Network Inc. stock. The healthcare sector generally experiences a period of seasonal strength from April 25 to December 4. However, only five years of data are available for BFLY, which may be insufficient for a fully reliable seasonal analysis.

Butterfly Network is a digital health and healthcare company focused on transforming medical imaging through its Ultrasound-on-Chip technology and ultrasound software solutions. Their products include handheld ultrasound probes like the Butterfly iQ, iQ+, and iQ3, along with software and AI solutions such as Compass enterprise workflow software, Compass AI, ScanLab, and Butterfly iQ+/iQ3 Vet. The company's strategy includes Butterfly Embedded for semiconductor co-development and Butterfly Garden for third-party app development.

Butterfly Network is headquartered in Burlington, Massachusetts, with additional offices in New York City and Palo Alto, California, and an international office in Taoyuan, Taiwan. Its devices are commercially available to trained healthcare practitioners in various regions globally, including parts of Africa, Asia, Australia, Europe, the Middle East, North America, and South America.

Butterfly Network has maintained a positive brand reputation, driven by its innovative technology and mission. The Butterfly iQ3 received the Best Medical Technology award at the 2024 Prix Galien USA Awards. The co-development partnership with Midjourney enhanced the company's reputation. Butterfly Network emphasizes its mission to democratize healthcare by making imaging more accessible and affordable globally.

Butterfly Network has a mixed ownership structure, with approximately 45.53% owned by institutional shareholders, 35.51% by insiders, and 18.96% by retail investors. Major institutional owners include BlackRock, Inc., Glenview Capital Management, Llc, and Vanguard Group Inc. The largest individual shareholder is Jonathan M. Rothberg, who owns 36.24 million shares, representing 13.87% of the company.